Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

Probiotic supplements may help reduce inflammation and oxidative stress in women with PCOS.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Perforin and granzyme-B may influence hormone levels in women with PCOS.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Women with excessive body hair often have higher male hormones and related health issues.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.